Researchers have found the first direct evidence that autoimmunity plays a role in Parkinson’s disease.
The discovery that pain receptors continue to function within nerves may lead to more effective pain medications with fewer side effects.
Those who grow anxious in social situations may feel tremendous pressure about fulfilling holiday obligations, particularly workplace ones.
The talk was part of this year's Nobel Week Dialogue, a daylong event that aims to stimulate global dialogue between science and society.
In January, the Nurse Practitioners Modernization Act will allow experienced New York nurse practitioners to practice more independently. Stephen Ferrara, DNP, explains.
Malaria drug resistance in Southeast Asia is caused by a single mutated gene in the disease-causing parasite, a Columbia-led study has found.
CUMC scientists have created a 3-D printed implant that stimulates stem cells to regenerate the meniscus, cartilage that cushions and protects the knee.
The founding director of Columbia’s Institute for Genomic Medicine explains how precision medicine is essential to practicing good medicine.
Two families—the Liebers and the Taubs—that have given generously to Columbia over the years received honors at the 2014 Crown Awards for their medical philanthropy.
As the Naomi Berrie Diabetes Center celebrates a milestone, its leadership looks to the day when a cure for diabetes might mean no more anniversaries.
Richard D. Carvajal, MD, has been named director of the Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center, effective Nov. 1, 2014.
Mailman School of Public Health researchers develop a model that forecasts the severity of flu and could have applications for predicting other infectious diseases.